News & Resources

Drug Studies’ Results Make Case for Access to All Opioid Dependence Medications

Dr. Joseph Garbely, D.O., FASAM, Vice President of Medical Services and Medical Director, Caron Treatment Centers, is reassured by results of two recent studies, that showed comparable efficacy and safety between sublingual buprenorphine and injectable naltrexone for opioid dependence.

See story in Addiction Professional

Addiction Professional

Related Content

Blog
Sep 28, 2018

Drug Detox and You—Are You Ready for a Change?

By Caron Staff

Read Article
Blog
Person laying in bed in the dark, the light from their phone screen shining on their face.
Mar 30, 2020

Healthy Digital Use or Dependence? The Facts May Surprise…

By Ryan Hanson

Read Article
Press Releases
Jun 21, 2019

“The Truth, the Whole Truth and Nothing but the Truth”…

By Caron Admin

Read Article